Essity achieved its highest-ever profit in 2024, with EBITA margin of 14.0% and ROCE of 17.6%. The company grew strongly in its most profitable categories and gained market shares, demonstrating the success of its strategy to accelerate profitable growth.

In 2024, Essity divested its 51.59% stake in Vinda (Asian hygiene company) for approximately SEK 19 billion, strengthening its portfolio for higher-margin, lower-volatility products and focusing on core markets.

Proposed dividend increased 6.5% to SEK 8.25 per share (vs SEK 7.75 in 2023). Essity also launched a SEK 3 billion share buyback program in 2024, with a new SEK 3 billion program announced for 2025, reflecting strong cash generation and commitment to shareholder returns.

Product Superiority: Achieved 70%+ (highest ever) | Limited Tariff Impact: Production close to customers mitigates trade risks | Growth Drivers: Higher prices, positive mix, premium products

Essity operates approximately 70 production facilities worldwide, enabling local production and supply chain optimization. Recent investments include a €24 million expansion in Tarragona, Spain for incontinence products, making it the first European plant to produce all product lines.

In 2024, 87% of Essity's innovations yielded social and/or environmental improvements, significantly exceeding the target of 50%. This demonstrates the company's commitment to developing sustainable solutions that benefit both people and planet.

Essity was named one of the world's 100 most sustainable companies by Corporate Knights and included in S&P Global's Sustainability Yearbook 2025. The company also partnered with the World Economic Forum to promote menstrual health globally.

Essity's brands are built on trust, scientific efficacy, and innovation. The company continuously invests in brand building and product development to maintain competitive advantages and customer loyalty across markets.

Essity will implement four business areas: Health & Medical, Personal Care, Consumer Tissue, and Professional Hygiene. This change decentralizes decision-making and strengthens end-to-end accountability to enhance customer focus, speed, and operational efficiency.

Magnus Groth successfully led Essity through significant transformation, increasing profitability, growth, and innovation. Under his leadership, Essity became a world-leading hygiene and health company with strong brands, recognized sustainability work, and profitable growth platform for continued global expansion.

Background: Previously President of Health & Medical business unit, member of Executive Management Team since 2015, extensive experience across innovation, production, and sales. Holds Master of Science in Engineering from Chalmers University of Technology. Brings engaging and positive leadership style with deep industry knowledge.

Innovation: Continuous product development and digital solutions | Sustainability: Circular economy and net zero commitment | Efficiency: Cost savings and operational excellence | Culture: Winning culture driving performance

Essity offers compelling investment opportunity as global hygiene and health leader with strong brands, record profitability, and clear sustainability commitments. The company's strategic restructuring, new leadership, and focus on high-margin categories position it well for continued profitable growth and value creation.